Hôpital Pierre Paul Riquet - CHU de Toulouse
Toulouse, 31049, France
NCT Number: NCT03689361
investigators hypothesize that T2 * vein abnormalities are frequent and are specific to the migraine aura.
Looking for future studies?
Notify Me18 year–55 year
All sexes
Interventional
Phase 4
Toulouse, 31049, France
The diagnosis of migraine aura is now based solely on clinical criteria and the assertion of the diagnosis on these clinical criteria alone proves difficult in the acute phase. Added to this difficulty, the symptomatology of a migraine aura can sometimes be similar to that of a stroke, so a diagnosis can be poorly established, resulting in poor patient care. The possibility of making the positive diagnosis of migraine aura on a routine MRI sequence, T2 *, would be an important advance for the management of these patients
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Routine MRI with all the sequences performed for the management of acute neurological deficit in the Toulouse Neuro Vascular Unit (diffusion, FLAIR, T2 *, vascular sequences (AngioRM and TOF) and perfusion).
MRI with all the sequences performed for the management of acute neurological deficit in the Toulouse Neuro Vascular Unit (diffusion, FLAIR, T2 *, vascular sequences (AngioRM and TOF) and perfusion)
telephone consultation
Time frame: Day 0
visible brain vein abnormalities on T2 * sequences MRI ,
Time frame: Day 0
in MRI , Overall visual assessment: presence or absence of hypoperfusion (presence or not in each anterior, middle and posterior territory) each lobe: Frontal, Temporal, Parietal, Occipital)
Time frame: Day 0
in MRI TOF
University Hospital, Toulouse
Other
Acronym: MARIE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07342296
Brain Diseases, Central Nervous System Diseases
View Trial DetailsNCT07021859
Brain Diseases, Central Nervous System Diseases
Glostrup Municipality, Denmark
View Trial DetailsNCT06409845
Brain Diseases, Central Nervous System Diseases
Florence, Italy
View Trial DetailsNCT05903040
Brain Diseases, Central Nervous System Diseases
Florence, Italy
View Trial Details